Largest $ Movers of Note - StreetInsider.com - 07/12/07

UPWARD MOVERS:
Alcan (NYSE: AL) +$9.00; Rio Tinto (NYSE: RTP) and Alcan reached an agreement for Rio Tinto to make an offer to acquire all of Alcan's outstanding common shares for US$101 per common share in a recommended, all cash transaction. The offer represents a total equity consideration for Alcan of approximately US$38.1 billion.

Mastercard Incorporated (NYSE: MA) +$7.59; Lehman Bros. reiterates a Buy rating on the stock.

Haynes International Inc. (Nasdaq: HAYN) +$5.81; Stock jumps with no specific news releases, but Steel & Iron sector is up 1.65% today

Century Aluminum Co. (Nasdaq: CENX) +$5.61; Stock jumps on news Alcan is being acquired by Rio Tinto.

Abercrombie & Fitch (NYSE: ANF) +$5.47; Said June comparable store sales increased 2%. The company reported net sales of $293.2 million for the five-week period ended July 7, 2007.


DOWNWARD MOVERS:
Rio Tinto (NYSE: RTP) -$10.00; Rio Tinto and Alcan reached an agreement for Rio Tinto to make an offer to acquire all of Alcan's outstanding common shares for US$101 per common share in a recommended, all cash transaction. The offer represents a total equity consideration for Alcan of approximately US$38.1 billion.

Mothers Work, Inc. (Nasdaq: MWRK) -$4.52; Company comparable store sales for June 2007 decreased 5.4%. Reported Q3 sales of $153.2 million vs. prior guidance of $160-166 million. Sees Q2 EPS between $0.86-0.90 vs. prior guidance of $1.25-1.55.

JoS. A. Bank Clothiers, Inc. (Nasdaq: JOSB) -$1.97; Announces that its total net sales for the fiscal month ended July 7, 2007 (fiscal June 2007) increased 11.5% to $53.2 million versus $47.7 million in the fiscal month ended July 1, 2006 (fiscal June 2006). Comparable store sales gained 0.4% in fiscal June 2007, as compared with fiscal June 2006, while Direct Marketing sales increased 32.9%. (Comparable same-store sales consensus was +1.7%)

Marriott International (NYSE: MAR) -$1.87; Reports Q2 EPS of $0.57, 4 cents better than estimates. Revenues were $3.2 billion vs. $3.17 billion consensus. Sees Q3 EPS between $0.27-0.31 vs. consensus of $0.37. Sees FY EPS between $1.88-1.96 vs. $1.92 consensus.

ImClone Systems (Nasdaq: IMCL) -$1.84; ImClone and Bristol-Myers (BMY) Announce Results From Phase III study of ERBITUX - Primary Endpoint Not Met.

You May Also Be Interested In

• Barclays reports U.S. hotel revenue per room up 8.2% in July
• BMO starts chip stocks coverage: Here are its preferred picks
• BTIG notes elevated delinquencies in Affirm ABS vintages